Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Is the Estimated Market Size of the Nuclear Medicine Diagnostics Market In 2029?
Recent years have seen a swift expansion in the size of the nuclear medicine diagnostics market. The market is expected to rise from $7.16 billion in 2024 to $7.88 billion in 2025, indicating a compound annual growth rate (CAGR) of 10.2%. Factors contributing to the growth during the historic period include progress in medical imaging, a rise in chronic disease cases, aging populace developments, the use in oncology clinical applications, and improved diagnostic precision and accuracy.
In the coming years, the nuclear medicine diagnostics market size is anticipated to undergo swift expansion. It is set to reach a size of $12.38 billion by 2029, with a compound annual growth rate (CAGR) of 11.9%. The expansion projected for this forecast period will likely be due to the diversified use of nuclear medicine in neurology, its amalgamation with other imaging procedures, advancements in precision medicine, the surging demand for theranostics, and worldwide initiatives towards disease eradication. The notable trends for this forecast period may include the transition towards a smaller, decentralized radiopharmacy model, the use of nuclear medicine in neurology, advancement in radiomics and quantitative imaging analysis, combined efforts for research and development, and emphasis on radiation safety and dosage measurement.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9415&type=smp
What External and Internal Drivers Are Contributing to the Growth of theNuclear Medicine Diagnostics Market?
The surge in demand for nuclear medicine diagnostics is predicted to drive the growth of its market in the future. Nuclear medicine utilizes radioactive substances within the body for disease diagnosis or for the purpose of targeting and eliminating harmful or damaged organs and tissues. Its diagnostic applications are mainly in radiation and similar life-threatening treatments. This escalating demand is due to benefits like precise results aiding in superior treatment decisions. For example, as per a report on nuclear medicine diagnostics by the World Nuclear Association, a UK-based international organization that advocates nuclear power, in April 2022, the annual treatments performed using nuclear medicine exceeded 40 million, and the requirement for radioisotopes is growing up to 5% annually. Furthermore, in over 10,000 hospitals globally, 90% of medical procedures involving radioisotopes are conducted. Therefore, as the demand for nuclear medicine diagnostics rises, so will the expansion of the nuclear medicine diagnostics market.
What Segment Types Define the Nuclear Medicine Diagnostics Market Structure?
The nuclear medicine diagnosticsmarket covered in this report is segmented –
1) By Type: SPECT Radiopharmaceuticals, PET Radiopharmaceuticals
2) By Application: Cardiology, Thyroid, Neurology, Oncology, Other Applications
3) By End-User: Hospitals And Diagnostic Centers, Research Institutes
Subsegments:
1) By SPECT Radiopharmaceuticals: Technetium-99m-Based Radiopharmaceuticals, Iodine-123-Based Radiopharmaceuticals, Thallium-201-Based Radiopharmaceuticals, Other SPECT Radiopharmaceuticals
2) By PET Radiopharmaceuticals: Fluorine-18-Based Radiopharmaceuticals, Carbon-11-Based Radiopharmaceuticals, Gallium-68-Based Radiopharmaceuticals, Other PET Radiopharmaceuticals
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=9415&type=smp
Which Geographic Areas Hold the Strongest Growth Potential in the Nuclear Medicine Diagnostics Market?
North America was the largest region in the nuclear medicine diagnostics market in 2024. The regions covered in the nuclear medicine diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Long-Term Trends Are Transforming the Competitive Landscape of the Nuclear Medicine Diagnostics Market?
Leading businesses in the nuclear medicine diagnostics market are concentrating on launching superior solutions, including avant-garde medical technologies, to strengthen their market position. Such innovative advances in the medical field aim to enhance patient results, improve care quality, and encourage overall wellness. For instance, Gleneagles Hospital, a company based in Malaysia that offers medical and healthcare services, inaugurated the Nuclear Medicine Unit in August 2023. This specific unit is a dedicated section within a hospital or medical center furnished with up-to-the-minute technology and proficient professionals. The ultimate purpose of this unit is to offer early disease detection, diagnosis, and treatment using nuclear medicine imaging approaches.
View the full report here:
https://www.thebusinessresearchcompany.com/report/nuclear-medicine-diagnostics-global-market-report
What Is the Definition of the Nuclear Medicine Diagnostics Market?
Nuclear medicine uses radioactive substances inside the body to diagnose illnesses or to target and remove diseased or damaged organs and tissue (for treatment). Nuclear medicine includes the use of radioactive drugs for research, therapeutic, and diagnostic purposes. Radioactive tracers are used in diagnostic nuclear medicine to visualize and/or measure the overall or local function of an organ.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9415
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model